By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Resverlogix Corporation 

4820 Richard Road SW
Suite 300
Calgary  Alberta  T3E 6L1  Canada
Phone: 403-254-9252 Fax: 403-256-8495


Company News
Resverlogix (RVX.TO) CEO Says It's in Talks With Suitors, After $100M in Q1 Deals 4/28/2015 6:32:05 AM
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+ 4/27/2015 5:59:57 AM
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015 6:21:48 AM
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms 3/19/2015 12:26:47 PM
Resverlogix Corporation (RVX.TO) Presents At The Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15) 3/16/2015 1:56:22 PM
Resverlogix Corporation (RVX.TO) Collaborates With Emerald Logic To Identify Factors Driving Drug Response And Efficacy In Phase 2 Program 3/4/2015 7:40:15 AM
Resverlogix Corporation (RVX.TO) Presents At Biotech Showcase During J.P. Morgan Week 1/15/2015 10:06:46 AM
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014 8:20:05 AM
Resverlogix Corporation (RVX.TO) Announces Annual General Meeting Voting Results 10/9/2014 9:23:51 AM
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014 7:54:11 AM